Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant)
Open Access
- 10 February 2015
- journal article
- case report
- Published by Hindawi Limited in Case Reports in Hematology
- Vol. 2015, 1-4
Abstract
Mast cell leukemia (MCL) is a very rare form of systemic mastocytosis (SM) with a short median survival of 6 months. We describe a case of a 65-year-old woman with aleukaemic variant of MCL with a very high serum total tryptase level of 2255μg/L at diagnosis, which occurred following an episode of hypotensive shock. She fulfilled the diagnostic criteria of SM, with a bone marrow smear infiltration of 5060% of atypical mast cells (MCs). She tested negative for the KIT D816V mutation, without any sign of organ damage (no B- or C-findings) and only few mediator-related symptoms. She was treated with antihistamine alone and then with imatinib for the appearance of anemia. She maintained stable tryptase level and a very indolent clinical course for twenty-two months; then, she suddenly progressed to acute MCL with a serum tryptase level up to 12960μg/L. The patient died due to haemorrhagic diathesis twenty-four months after diagnosis. This clinical case maybe represents an example of the chronic form of mast cell leukemia, described as unpredictable disease, in which the serum total tryptase level has confirmed itself as a reliable marker of mast cells burden regardless of the presence of other signs or symptoms.Keywords
This publication has 8 references indexed in Scilit:
- Chronic mast cell leukemia: A novel leukemia-variant with distinct morphological and clinical featuresLeukemia Research, 2015
- Mast cell leukemiaBlood, 2013
- Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2011
- The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non–mast cell lineage disease (SM-AHNMD)Blood, 2010
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsBlood, 2009
- Diagnostic Value of Tryptase in Anaphylaxis and MastocytosisImmunology and Allergy Clinics of North America, 2006
- Mast cell proliferative disorders: current view on variants recognized by the World Health OrganizationHematology/Oncology Clinics of North America, 2003
- Mast cells and mast cell neoplasia: a review*Histopathology, 1979